2017
DOI: 10.1177/0033354917743500
|View full text |Cite
|
Sign up to set email alerts
|

Where Next for Opioids and the Law? Despair, Harm Reduction, Lawsuits, and Regulatory Reform

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 34 publications
0
4
0
Order By: Relevance
“…The trainer workshops lasted 4 h and covered: [1] background and rationale for the SL program, [2] mechanisms of an OD, [3] identifying and responding to an OD, [4] effects of naloxone, [5] assembling the naloxone kit and administrating the naloxone, [6] pulmonary resuscitation [PR] using a standard reanimation “AmbuMan” training mannequin, [7] project documentation, and [8] implementation procedures at the local sites.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…The trainer workshops lasted 4 h and covered: [1] background and rationale for the SL program, [2] mechanisms of an OD, [3] identifying and responding to an OD, [4] effects of naloxone, [5] assembling the naloxone kit and administrating the naloxone, [6] pulmonary resuscitation [PR] using a standard reanimation “AmbuMan” training mannequin, [7] project documentation, and [8] implementation procedures at the local sites.…”
Section: Methodsmentioning
confidence: 99%
“…Further, the SL project coordinator (a registered nurse) supervised the trainers when they conducted their first helper workshop. The helper workshop lasted 1 h, involved 5–6 participants, and covered [1] participant experience with ODs and risk behavior [2]; introduction to the naloxone kit and intranasal spray [3]; resuscitation training.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…(12,13) In the United States, common harm reduction strategies include syringe services programs (SSPs) to reduce risk of injection-associated infections (14)(15)(16)(17); overdose education and naloxone distribution (OEND) to prevent fatal overdose (18,19); and low-barrier access to medications for opioid use disorder (MOUD) to facilitate patient engagement in care and reduce mortality. (20)(21)(22) Although harm reduction services are highly evidence-based and effective, their implementation in most healthcare settings has been limited, in part due to federal legislation (23,24). Under current models, the vast majority of harm reduction services are provided through community-based public health organizations.…”
mentioning
confidence: 99%